Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1Phase 2/3 1Phase 1/2 1Phase 1 1

Status

Recruiting 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 1

Conditions

Breast Neoplasms 102Carcinoma, Non-Small-Cell Lung 94Multiple Myeloma 85Prostatic Neoplasms 74Neoplasms 57Colorectal Neoplasms 57Leukemia, Myeloid, Acute 56Lymphoma 50Lung Neoplasms 43Squamous Cell Carcinoma of Head and Neck 42Neoplasm Metastasis 38Pancreatic Neoplasms 36Melanoma 35Ovarian Neoplasms 34Lymphoma, Non-Hodgkin 34Lymphoma, Large B-Cell, Diffuse 34Carcinoma, Hepatocellular 34Precursor Cell Lymphoblastic Leukemia-Lymphoma 31Urinary Bladder Neoplasms 30Head and Neck Neoplasms 30Carcinoma, Renal Cell 28Myelodysplastic Syndromes 27Leukemia, Lymphocytic, Chronic, B-Cell 27Hodgkin Disease 27Triple Negative Breast Neoplasms 26Sarcoma 26Hematologic Neoplasms 26Recurrence 25Glioma 25Endometrial Neoplasms 23

Interventions

remdesivir 1Specimen Handling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Autoimmune Diseases × 30 days × Clear all
NCT06817889 2026-06-03

Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals

Fred Hutchinson Cancer Center

Phase 2 Recruiting
60 enrolled

Autoimmune Diseases, Respiratory Syncytial Virus Infections

NCT03922724 2026-06-02

Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma

National Institutes of Health Clinical Center (CC)

Phase 2 Recruiting
330 enrolled
Lymphoid

Autoimmune Diseases, Immune System Diseases, Lymphoproliferative Disorders, Opportunistic Infections, Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡